The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...
The collaborations will provide Illumina's customers with workflows for genomic disease characterization and spatial mapping.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results